MoonLake Immunotherapeutics (NASDAQ: MLTX)

United States

Member Since:Mar 05, 2024

Ownership:N/A

Number of Offices:N/A

Total Employees:11–50

Established In:2021

MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.

No record available!